XML 44 R29.htm IDEA: XBRL DOCUMENT v3.4.0.3
Earnings per Share (Tables)
 6 Months Ended
Mar. 31, 2016
Earnings Per Share [Abstract]  
Net components of basic and diluted earnings per share
Components of basic and diluted (loss) earnings per share and excluded anti-dilutive potential common shares are as follows: 
 
Three Months Ended March 31,
 
Six Months Ended March 31,
 
2016
 
2015
 
2016
 
2015
 
 
 
 
 
 
 
 
 
(in thousands, except per share amounts)
Net (loss) income from continuing operations attributable to EZCORP (A)
$
(73,031
)
 
$
(3,388
)
 
$
(80,267
)
 
$
1,347

Income (loss) from discontinued operations, net of tax (B)
(1,094
)
 
4,731

 
(1,332
)
 
11,608

Net (loss) income attributable to EZCORP (C)
$
(74,125
)
 
$
1,343

 
$
(81,599
)
 
$
12,955

 
 
 
 
 
 
 
 
Weighted-average outstanding shares of common stock (D)
54,843

 
54,184

 
54,869

 
53,915

Dilutive effect of restricted stock*
—

 
—

 
—

 
57

Weighted-average common stock and common stock equivalents (E)
54,843


54,184


54,869


53,972

 
 
 
 
 
 
 
 
Basic (loss) earnings per share attributable to EZCORP:
 
 
 
 
 
 
 
Continuing operations (A / D)
$
(1.33
)
 
$
(0.06
)
 
$
(1.46
)
 
$
0.02

Discontinued operations (B / D)
(0.02
)
 
0.09

 
(0.02
)
 
0.22

Basic (loss) earnings per share (C / D)
$
(1.35
)
 
$
0.03

 
$
(1.48
)
 
$
0.24

 
 
 
 
 
 
 
 
Diluted (loss) earnings per share attributable to EZCORP:
 
 
 
 
 
 
 
Continuing operations (A / E)
$
(1.33
)
 
$
(0.06
)
 
$
(1.46
)
 
$
0.02

Discontinued operations (B / E)
(0.02
)
 
0.09

 
(0.02
)
 
0.22

Diluted (loss) earnings per share (C / E)
$
(1.35
)
 
$
0.03

 
$
(1.48
)
 
$
0.24

 
 
 
 
 
 
 
 
Potential common shares excluded from the calculation of diluted (loss) earnings per share:
 
 
 
 
 
 
 
Restricted stock**
1,608

 
273

 
1,545

 
6

Warrants***
14,317

 
14,317

 
14,317

 
14,317

Total potential common shares excluded
15,925

 
14,590

 
15,862

 
14,323


*
As required by FASB ASC 260-10-45-19, amount excludes all potential common shares for periods when there is a loss from continuing operations.
**
Includes antidilutive share-based awards as well as performance-based and market conditioned share-based awards that are contingently issuable, but for which the condition for issuance has not been met as of the end of the reporting period.
***
See Note 7 for discussion of the terms and conditions of these potential common shares.